DK2011880T3 - Taurin transportergen - Google Patents

Taurin transportergen

Info

Publication number
DK2011880T3
DK2011880T3 DK07741485.2T DK07741485T DK2011880T3 DK 2011880 T3 DK2011880 T3 DK 2011880T3 DK 07741485 T DK07741485 T DK 07741485T DK 2011880 T3 DK2011880 T3 DK 2011880T3
Authority
DK
Denmark
Prior art keywords
taurin
transportation
taurin transportation
Prior art date
Application number
DK07741485.2T
Other languages
English (en)
Inventor
Hisahiro Tabuchi
Tomoya Sugiyama
Saeko Tanaka
Satoshi Tainaka
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DK2011880T3 publication Critical patent/DK2011880T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2500/00—Specific components of cell culture medium
    • C12N2500/30—Organic components
    • C12N2500/32—Amino acids
    • C12N2500/33—Amino acids other than alpha-amino carboxylic acids, e.g. beta-amino acids, taurine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Cell Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK07741485.2T 2006-04-13 2007-04-12 Taurin transportergen DK2011880T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006110467 2006-04-13
PCT/JP2007/058049 WO2007119774A1 (ja) 2006-04-13 2007-04-12 タウリントランスポーター遺伝子

Publications (1)

Publication Number Publication Date
DK2011880T3 true DK2011880T3 (da) 2012-11-26

Family

ID=38609534

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07741485.2T DK2011880T3 (da) 2006-04-13 2007-04-12 Taurin transportergen

Country Status (11)

Country Link
US (1) US9238687B2 (da)
EP (2) EP2011880B1 (da)
JP (2) JP4977691B2 (da)
KR (1) KR101342172B1 (da)
CN (1) CN101421411B (da)
AU (1) AU2007239679B2 (da)
CA (1) CA2649148C (da)
DK (1) DK2011880T3 (da)
ES (1) ES2397383T3 (da)
TW (1) TWI388664B (da)
WO (1) WO2007119774A1 (da)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2011880T3 (da) 2006-04-13 2012-11-26 Chugai Pharmaceutical Co Ltd Taurin transportergen
JP5635260B2 (ja) 2007-03-15 2014-12-03 中外製薬株式会社 ポリペプチドの製造方法
WO2008136398A1 (ja) * 2007-04-26 2008-11-13 Chugai Seiyaku Kabushiki Kaisha 高濃度アミノ酸含有培地を用いた細胞の培養方法
CA2695849C (en) 2007-08-07 2018-10-16 Chugai Seiyaku Kabushiki Kaisha Method of producing heterogeneous proteins
RU2486245C2 (ru) * 2007-10-15 2013-06-27 Чугаи Сейяку Кабусики Кайся Способ получения клетки, способной продуцировать гетеропротеины с высоким выходом
AU2008314973C1 (en) 2007-10-24 2014-05-08 Chugai Seiyaku Kabushiki Kaisha A cell for use in production of heteroproteins and production method using the same
JP5749930B2 (ja) 2008-10-28 2015-07-15 中外製薬株式会社 ペプチド含有動物細胞培養用培地
WO2010084947A1 (ja) * 2009-01-23 2010-07-29 中外製薬株式会社 異種ポリペプチドの製造方法
US8741601B2 (en) 2009-04-22 2014-06-03 Chugai Seiyaku Kabushiki Kaisha Method for producing a cell capable of high-yield production of heteroproteins
TWI647309B (zh) 2011-04-01 2019-01-11 Chugai Seiyaku Kabushiki Kaisha 重組多肽之製造方法
SG11201502801RA (en) * 2012-10-10 2015-06-29 Chugai Pharmaceutical Co Ltd Method for establishing modified host cell
TW202440903A (zh) 2015-08-04 2024-10-16 美商再生元醫藥公司 補充牛磺酸之細胞培養基及用法(一)
SG10201607778XA (en) 2016-09-16 2018-04-27 Chugai Pharmaceutical Co Ltd Anti-Dengue Virus Antibodies, Polypeptides Containing Variant Fc Regions, And Methods Of Use

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9019812D0 (en) 1990-09-11 1990-10-24 Scotgen Ltd Novel antibodies for treatment and prevention of infection in animals and man
EP0631623A4 (en) 1992-03-04 1996-09-25 Synaptic Pharma Corp DNA CODING FOR TAURINE AND GABA TRANSPORTERS AND THEIR USE.
US6225115B1 (en) 1992-03-04 2001-05-01 Synaptic Pharmaceutical Corporation DNA encoding taurine and GABA transporters and uses thereof
JP3630453B2 (ja) 1994-09-30 2005-03-16 中外製薬株式会社 Il−6レセプター抗体を有効成分とする未熟型骨髄腫細胞治療剤
AU695117B2 (en) * 1994-10-06 1998-08-06 Hoechst Aktiengesellschaft Regulated genes by stimulation of chondrocytes with IL-1beta
JPH09203734A (ja) 1996-01-26 1997-08-05 Sumitomo Electric Ind Ltd 抗血清、抗体、リガンド及びそれらの検出方法
JPH1075787A (ja) 1996-09-02 1998-03-24 Asahi Chem Ind Co Ltd 変異型アラニンアミノトランスフェラーゼおよびその製造法
JPH10191984A (ja) 1997-01-09 1998-07-28 Oriental Yeast Co Ltd 活性型ヒトaltの製造法
DE19855313A1 (de) 1998-12-01 2000-06-08 Degussa Verfahren zur fermentativen Herstellung von D-Pantothensäure durch Verstärkung des panD-Gens in Mikroorganismen
AU7703400A (en) 1999-09-14 2001-04-17 Xenoport, Inc. Substrates and screening methods for transport proteins
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
CN1636058B (zh) 2001-05-14 2011-06-08 龚大为 新型丙氨酸转氨酶及其应用方法
JP4435563B2 (ja) * 2001-07-10 2010-03-17 バイオジェン アイデック インク アポトーシスプロセスの阻害および細胞性能の改善
US20030138417A1 (en) 2001-11-08 2003-07-24 Kaisheva Elizabet A. Stable liquid pharmaceutical formulation of IgG antibodies
US7309597B2 (en) 2002-01-18 2007-12-18 Cargill, Incorporated Alanine 2,3-Aminomutase
US20050265983A1 (en) 2002-11-17 2005-12-01 Eldad Melamed Methods, nucleic acid constructs and cells for treating neurodegenerative disorders
IL152905A0 (en) 2002-11-17 2003-06-24 Univ Ramot Dopaminergic markers induction in neuronal-like cells isolated from adult human bone marrow stromal cells: implications for novel gene therapy strategy for parkinsons disease
US20030165495A1 (en) 2003-04-01 2003-09-04 Carulli John P. Nucleic acids and polypeptides
WO2005076015A1 (en) * 2004-01-30 2005-08-18 Xenoport, Inc. Taurine transporter tau1 expressed in blood brain barrier cells
KR100789645B1 (ko) * 2004-04-14 2007-12-27 주식회사유한양행 B형 간염바이러스의 s-표면항원을 인식하는 인간화 항체및 이의 제조방법
AU2005256113B2 (en) 2004-07-09 2011-02-10 Chugai Seiyaku Kabushiki Kaisha Anti-glypican 3 antibody
CN1838969A (zh) 2004-10-07 2006-09-27 三仪股份有限公司 经皮和经粘膜制剂
JP2006110467A (ja) 2004-10-14 2006-04-27 Furukawa Co Ltd 半導体製造装置用燐分離装置
PA8672101A1 (es) 2005-04-29 2006-12-07 Centocor Inc Anticuerpos anti-il-6, composiciones, métodos y usos
US20070207152A1 (en) 2005-11-09 2007-09-06 Brophy Susan E Human BNP immunospecific antibodies
EP1983819A4 (en) 2005-12-23 2009-09-02 Arcadia Biosciences Inc Nitrogen-efficient monocot plants
DK2011880T3 (da) 2006-04-13 2012-11-26 Chugai Pharmaceutical Co Ltd Taurin transportergen
JP5635260B2 (ja) 2007-03-15 2014-12-03 中外製薬株式会社 ポリペプチドの製造方法
CA2695849C (en) 2007-08-07 2018-10-16 Chugai Seiyaku Kabushiki Kaisha Method of producing heterogeneous proteins
RU2486245C2 (ru) 2007-10-15 2013-06-27 Чугаи Сейяку Кабусики Кайся Способ получения клетки, способной продуцировать гетеропротеины с высоким выходом
AU2008314973C1 (en) 2007-10-24 2014-05-08 Chugai Seiyaku Kabushiki Kaisha A cell for use in production of heteroproteins and production method using the same
US8741601B2 (en) 2009-04-22 2014-06-03 Chugai Seiyaku Kabushiki Kaisha Method for producing a cell capable of high-yield production of heteroproteins

Also Published As

Publication number Publication date
WO2007119774A1 (ja) 2007-10-25
HK1128308A1 (en) 2009-10-23
CN101421411A (zh) 2009-04-29
TWI388664B (zh) 2013-03-11
CA2649148C (en) 2016-08-23
EP2228450A1 (en) 2010-09-15
EP2011880B1 (en) 2012-10-24
JP2012143247A (ja) 2012-08-02
TW200806790A (en) 2008-02-01
EP2011880A4 (en) 2009-11-11
KR20090007276A (ko) 2009-01-16
JPWO2007119774A1 (ja) 2009-08-27
US20090191591A1 (en) 2009-07-30
AU2007239679A1 (en) 2007-10-25
JP5399529B2 (ja) 2014-01-29
CN101421411B (zh) 2015-06-03
US9238687B2 (en) 2016-01-19
ES2397383T3 (es) 2013-03-06
KR101342172B1 (ko) 2013-12-20
AU2007239679B2 (en) 2012-10-11
JP4977691B2 (ja) 2012-07-18
EP2011880A1 (en) 2009-01-07
CA2649148A1 (en) 2007-10-25

Similar Documents

Publication Publication Date Title
BRPI0720886A2 (pt) Recipiente
ATE501940T1 (de) Behälteranordnung
DE602006021277D1 (de) Behälter
DE602006021279D1 (de) Behälter
DOS2006000040S (es) Contenedor
DE112006003701A5 (de) Palette
DE502007006720D1 (de) Flurförderzeug
DK2102085T3 (da) Transportindretning
ITMI20060096U1 (it) Involucro da spedizione
DOS2005000217S (es) Contenedor
DK2086334T3 (da) Transportindretning
DE112005003512A5 (de) Transportbehälter
ES1059661Y (es) Contenedor
DK2214947T3 (da) Kombinationsvogn
ES1063085Y (es) Contenedor
ES1064346Y (es) Recipiente
ES1060819Y (es) Envase
ITMO20050194A1 (it) Contenitore
FI7410U1 (fi) Kuljetussäiliö
FI7037U1 (fi) Kuljetuskontti
FIU20060491U0 (fi) Kuljetussäiliö
SE0600669L (sv) Lastsäkring
ES1063524Y (es) Envase
ES1064502Y (es) Envase
ATE480466T1 (de) Behälter